Marie-Lise Gougeon Selected Research

Marie-Lise Gougeon Research Topics

Disease

9	Infections 12/2020 - 04/2004
5	HIV Infections (HIV Infection) 01/2011 - 02/2002
4	Neoplasms (Cancer) 01/2018 - 10/2005
4	Human Influenza (Influenza) 12/2015 - 02/2012
4	Acquired Immunodeficiency Syndrome (AIDS) 03/2013 - 03/2002
3	Disease Progression 01/2021 - 04/2003
3	Virus Diseases (Viral Diseases) 01/2020 - 02/2016
2	Neuroinflammatory Diseases 01/2021 - 02/2017
2	Neurocognitive Disorders (Clerambault Syndrome) 03/2017 - 02/2017
2	Inflammation (Inflammations) 02/2017 - 11/2011
2	Necrosis 01/2017 - 05/2003
2	Melanoma (Melanoma, Malignant) 04/2015 - 10/2005
1	Nausea 01/2021
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 01/2021
1	Zika Virus Infection 01/2020
1	Measles 10/2017
1	Yellow Fever 10/2017
1	Rubella (German Measles) 10/2017
1	Mumps 10/2017
1	Brain Injuries (Brain Injury) 02/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2015
1	Chronic Disease (Chronic Diseases) 01/2014
1	Sarcoma (Soft Tissue Sarcoma) 03/2013
1	Stiff-Person Syndrome (Stiff Man Syndrome) 05/2010
1	Bacillary Dysentery (Shigellosis) 02/2009
1	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2008
1	Nijmegen Breakage Syndrome 06/2008
1	Pemphigus (Pemphigus Vulgaris) 08/2007
1	Pyelonephritis 08/2007
1	Body Weight (Weight, Body) 08/2007
1	Sepsis (Septicemia) 08/2007
1	Autoimmune Diseases (Autoimmune Disease) 06/2007
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2007
1	Diabetes Mellitus 04/2004
1	Lipodystrophy 04/2004
1	Insulin Resistance 04/2004

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 01/2021 - 02/2009
4	AntibodiesIBA 10/2017 - 01/2002
4	HMGB1 Protein (HMG1)IBA 03/2017 - 01/2008
3	Antiviral Agents (Antivirals)IBA 12/2020 - 02/2016
2	alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)IBA 01/2021 - 01/2017
2	Purinergic Receptors (Receptors, Purine)IBA 01/2019 - 08/2011
2	AntigensIBA 01/2017 - 06/2007
2	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2015 - 01/2014
2	Interleukin-2 (IL2)IBA 07/2009 - 10/2005
2	Immunoglobulins (Immunoglobulin)IBA 08/2007 - 06/2007
1	Acetylglucosaminidase (NAGase)IBA 01/2021
1	ChemokinesIBA 01/2021
1	CytokinesIBA 01/2021
1	EnzymesIBA 01/2021
1	NucleotidesIBA 01/2019
1	NLR ProteinsIBA 01/2019
1	Leucine (L-Leucine)FDA Link 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Rubella VaccineIBA 10/2017
1	Measles VaccineIBA 10/2017
1	Neutralizing AntibodiesIBA 10/2017
1	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 10/2017
1	Immunoglobulin G (IgG)IBA 02/2017
1	Immunologic Factors (Immunomodulators)IBA 12/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2015
1	CalreticulinIBA 04/2015
1	Interleukin-6 (Interleukin 6)IBA 04/2015
1	Melphalan (Alkeran)FDA LinkGeneric 04/2015
1	Interleukin-8 (Interleukin 8)IBA 04/2015
1	LigandsIBA 03/2013
1	Protein Isoforms (Isoforms)IBA 03/2013
1	Biological ProductsIBA 06/2012
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2012
1	Peptides (Polypeptides)IBA 02/2012
1	Hemagglutinins (Hemagglutinin)IBA 02/2012
1	EpitopesIBA 02/2012
1	Complement C3b (C3bi)IBA 11/2011
1	Staphylococcal Protein A (Protein A)IBA 09/2011
1	AlarminsIBA 09/2011
1	Adenosine Triphosphate (ATP)IBA 08/2011
1	AutoantibodiesIBA 05/2010
1	Immunoglobulin A (IgA)IBA 02/2009
1	Proteins (Proteins, Gene)FDA Link 06/2008
1	Histones (Histone)IBA 06/2008
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 06/2008
1	Prednisone (Sone)FDA LinkGeneric 08/2007
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2007
1	Rituximab (Mabthera)FDA Link 08/2007
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 06/2007
1	Myelin-Oligodendrocyte GlycoproteinIBA 04/2007
1	MART-1 AntigenIBA 10/2005
1	HLA-A*02:01 antigenIBA 10/2005
1	NucleosidesIBA 04/2004
1	Reverse Transcriptase InhibitorsIBA 04/2004
1	Viral Protease InhibitorsIBA 04/2004
1	Apoptosis Regulatory ProteinsIBA 05/2003
1	Dactinomycin (Actinomycin)FDA LinkGeneric 04/2003

Therapy/Procedure

9	Therapeutics 01/2021 - 04/2004
3	Highly Active Antiretroviral Therapy (HAART) 02/2017 - 02/2002
2	Drug Therapy (Chemotherapy) 01/2018 - 04/2015
1	Radiotherapy 01/2018
1	Contraindications 08/2007